Parents’ and Health Professionals’ Attitudes to Advancing Primary MMR Vaccine Administration from Fifteen to Six Months of Age—A Qualitative Thematic Analysis Embedded in a Randomized Trial
Declining levels and duration of passively acquired maternal antibodies prompted a Danish trial to test the feasibility of advancing administration of the first measles, mumps, and rubella vaccine (MMR1) from 15 to 6 months of age. A trial-embedded qualitative study aimed to understand parents’ (<...
Main Authors: | Ann-Britt Kiholm Kirkedal, Julie Elkjær Møller, Lone Graff Stensballe, Vibeke Zoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/1/67 |
Similar Items
-
Implementation of the preventive vacc ination program against measles, mumps, and rubella (MMR) on the example of a selected clinic in the city of Krakow
by: Marek Wojczyk, et al.
Published: (2020-06-01) -
MMR-Varicella Vaccine and Risk of Febrile Seizures
by: J Gordon Millichap
Published: (2010-09-01) -
Nurses’ Perceptions Of MMR Vaccine Hesitancy In An Area With Low Vaccination Coverage
by: Jama A, et al.
Published: (2019-12-01) -
Immunogenicity and reactogenicity following MMR vaccination in 5–7-month-old infants: a double-blind placebo-controlled randomized clinical trial in 6540 Danish infantsResearch in context
by: Dorthe Maria Vittrup, et al.
Published: (2024-02-01) -
Immune response to the mumps component of the MMR vaccine in the routine of immunisation services in the Brazilian National Immunisation Program
by: Eliane Matos dos Santos, et al.
Published: (2014-06-01)